- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02207647
Prevalence of Pathogens in Cerebrospinal Fluid Obtained From Emergency Department Patients
April 18, 2022 updated by: David A. Talan, Olive View-UCLA Education & Research Institute
Of all emergency room patients, persons presenting with encephalitis/meningitis syndrome of a potentially infectious nature are among those of greatest concern.
Routine clinical and laboratory evaluation of such patients involves screening for known infectious disease agents, selection of which is nonstandardized.
Progress in diagnostic technologies, especially molecular techniques based on genetic characteristics of potential pathogens, has greatly expanded the investigators capacity to evaluate specimens from patients for a much wider range of potential pathogens (bacterial, viral, fungal and parasitic agents).
Use of Polymerase Chain Reaction (PCR) technology offers the possibility of identifying causative agents for the approximately 50% of all such presentations which go un-diagnosed.
The investigators propose a study involving a collaboration between the EMERGEncy ID NET, a network of 10 geographically diverse university-affiliated urban emergency departments (coordinated by Olive View-UCLA Medical Center) and the Centers for Disease Control and Prevention (CDC), to use these new technologies to address this issue.
Study Overview
Status
Terminated
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Sylmar, California, United States, 91342
- Olive View-UCLA Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 months and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
This study will be conducted by the Emergency ID Net Study group (P.I.
David Talan), which consists of a network of 10 emergency departments in university-affiliated hospitals throughout the United States.
Description
Inclusion Criteria:
- Age > or = 3 months old
- Receiving a Lumbar Puncture in the emergency department as part of their standard care.
Exclusion Criteria:
- No CSF available
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients with syndromes requiring lumbar puncture
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
prevalence of pathogens
Time Frame: 2 years
|
We will describe the range and proportion of pathogens found in CSF among patients enrolled over a 2 year period.
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2014
Primary Completion (Actual)
July 1, 2016
Study Completion (Actual)
December 1, 2021
Study Registration Dates
First Submitted
July 31, 2014
First Submitted That Met QC Criteria
August 1, 2014
First Posted (Estimate)
August 4, 2014
Study Record Updates
Last Update Posted (Actual)
April 20, 2022
Last Update Submitted That Met QC Criteria
April 18, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12H-770352
- U01CK000176 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Meningoencephalitis
-
Institute of Tropical Medicine, BelgiumUniversiteit Antwerpen; Victor Babes Hospital, Bucharest, RomaniaWithdrawnOxidative Stress | West Nile Virus | West Nile Fever | West Nile Fever Encephalitis | West Nile Fever Meningitis | West Nile Meningitis | West Nile Virus Meningoencephalitis | West Nile Fever Meningoencephalitis | West Nile Fever With Neurologic ManifestationRomania
-
Assistance Publique Hopitaux De MarseilleUnknownMeningo-encephalitis | Community-based MeningitisFrance
-
Wen-hong ZhangRecruitingEncephalitis | Meningitis | Meningoencephalitis | Next-Generation Sequencing | Polymerase Chain ReactionChina
-
Oxford University Clinical Research Unit, VietnamUniversity of Rochester; University of Liverpool; Liverpool School of Tropical... and other collaboratorsCompletedHiv | Meningitis | Meningoencephalitis | Meningitis StreptococcalVietnam
-
University of RostockCompletedCentral Nervous System Diseases | Delirium | Brain Injuries | Critical Illness | Encephalopathy | Inflammatory DiseaseGermany
-
University of MichiganCompletedNeuropsychiatric Systemic Lupus ErythematosusUnited States
-
Northwell HealthCompletedSystemic Lupus ErythematosusUnited States
-
University of New MexicoWithdrawnSystemic Lupus ErythematosusUnited States
-
Gilead SciencesUnited States Department of DefenseCompletedLupus Erythematosus, Systemic | Lupus Nephritis | Lupus Vasculitis, Central Nervous System | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States
-
University of MichiganCompletedSystemic Lupus Erythematosus | Fibromyalgia | Acute Neuropsychiatric LupusUnited States
Clinical Trials on no intervention
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
Wright State UniversityCompleted